Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on metformin effects for cardiovascular function in adolescents with type 1 diabetes; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2020-02-05